1-20 of 38
Jin S. Im
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with High Risk or Refractory/Relapsed Acute Myeloid Leukemia Following Allogeneic Stem Cell Transplantation

Gheath Alatrash, Cristina Knape, Laura Whited, Dawen Sui, Cara L Haymaker, Jason Yeh, Megan Marcotulli, Pariya Sukhumalchandra, Lisa St. John, Hsinyi Lu, Daniela E. Duenas, Ignacio Wistuba, Julia Mendoza Perez, Beatriz Sanchez Espiridion, Roland L. Bassett, Tapan M. Kadia, Courtney D. DiNardo, Farhad Ravandi, Jeremy Ramdial, Rohtesh S. Mehta, Amin M. Alousi, Betul Oran, Issa F. Khouri, Qaiser Bashir, Chitra Hosing, Muzaffar H. Qazilbash, Jin S. Im, Partow Kebriaei, Pavan Bachireddy, Jeffrey J. Molldrem, Jeffrey L. Jorgensen, Sa A. Wang, Wei WANG, Uday Popat, Elizabeth J. Shpall, Richard E. Champlin, Hagop M. Kantarjian, Naval Daver
Journal: Blood
Blood (2024) 144 (Supplement 1): 1047.
https://doi.org/10.1182/blood-2024-211343
Published: 2024
Journal Articles

Phase II Clinical Trial of “Off-the-Shelf” NK Cells with Allogeneic Stem Cell Transplantation in Patients with High-Risk Myeloid Malignancies

Jeremy Ramdial, Lorlyn Clemente, Pinaki Banerjee, Bouthaina S. Dabaja, Gheath Al-Atrash, Amin M. Alousi, Betul Oran, Uday Popat, Jin S. Im, Samer A. Srour, George Chen, Partow Kebriaei, Chitra Hosing, David Marin, Katayoun Rezvani, Elizabeth J. Shpall, Richard E. Champlin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4841.
https://doi.org/10.1182/blood-2024-211389
Published: 2024
Journal Articles

Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation

Abel Trujillo-Ocampo, Maison Grefe, Pamella Borges, Jelita Clinton, Hong He, Dan Li, Ling Yu, Martiela Vaz de Freitas, Lisa St. John, Karen Clise-Dwyer, Gheath Alatrash, Dinler Amaral Antues, Qing Ma, Jeffrey J. Molldrem, Elizabeth J. Shpall, Jin S. Im
Journal: Blood
Blood (2024) 144 (Supplement 1): 4818.
https://doi.org/10.1182/blood-2024-210168
Published: 2024
Journal Articles

Fractionated Busulfan, Fludarabine and Thiotepa Myeloablative Conditioning to Improve Transplant Outcomes for Myelofibrosis

Samer A. Srour, Rima M. Saliba, Jeremy Ramdial, Portia Smallbone, Jin S. Im, Amanda L. Olson, Crystal Carmicheal Kusy, Betul Oran, George Chen, Muzaffar H. Qazilbash, Partow Kebriaei, Chitra Hosing, Issa F. Khouri, Amin M. Alousi, Qaiser Bashir, David Marin, Yago Nieto, Elizabeth J. Shpall, Richard E. Champlin, Uday Popat
Journal: Blood
Blood (2024) 144 (Supplement 1): 3514.
https://doi.org/10.1182/blood-2024-211371
Published: 2024
Journal Articles

Addition of Inotuzumab Ozogamicin to Melphalan Plus Fludarabine Reduced-Intensity Conditioning Regimen of Allogeneic Transplantation in Patients with Acute Lymphoblastic Leukemia and Aggressive Lymphoid Malignancies: A Phase II Prospective Trial

Issa F. Khouri, Hagop M. Kantarjian, Alison M. Gulbis, Manuel M. Christopher, Fadi G. Haddad, Hussein A. Abbas, Bofei Wang, Koji Sasaki, Nitin Jain, Tapan M. Kadia, David Marin, Elizabeth J. Shpall, Gabriela Rondon, Hind Rafei, Jeremy Ramdial, Jin S. Im, Partow Kebriaei, Wei Qiao, Richard E. Champlin, Elias Jabbour
Journal: Blood
Blood (2024) 144 (Supplement 1): 2124.
https://doi.org/10.1182/blood-2024-203864
Published: 2024
Journal Articles

Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 Trial

Uday Popat, Roland L. Bassett, Amin M. Alousi, Gheath Alatrash, Yosra M. Aljawai, Qaiser Bashir, George Chen, Warren B. Fingrut, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Muzaffar H. Qazilbash, Jeremy Ramdial, Neeraj Y. Saini, Portia Smallbone, Samer A. Srour, Benigno C. Valdez, Richard E. Champlin, Borje S. Andersson, Elizabeth J. Shpall
Journal: Blood
Blood (2024) 144 (Supplement 1): 506.
https://doi.org/10.1182/blood-2024-203338
Published: 2024
Journal Articles

Addition of Inotuzumab Ozogamicin to the Conditioning Regimen of Allogeneic Stem Cell Transplantation (allo-SCT) for Relapsed CD22 (+) Lymphoid Malignancies: Long-Term Survival Results

Issa F. Khouri, Kamal Alzahrani, Alison Gulbis, Koji Sasaki, Nitin Jain, Nicholas J. Short, Tapan M. Kadia, May Daher, MD, Hind Rafei, Jin S Im, David Marin, Amanda L. Olson, Uday R. Popat, Muzaffar H. Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A. Srour, Partow Kebriaei, Elizabeth J. Shpall, Hagop M. Kantarjian, Richard E. Champlin, Elias Jabbour
Journal: Blood
Blood (2023) 142 (Supplement 1): 233.
https://doi.org/10.1182/blood-2023-181880
Published: 2023
Journal Articles

Predictors for Survival and Relapse in Patients (pts) with Diffuse Large b-Cell Lymphoma (DLBCL) Treated with Anti-CD19 CAR T-Cell Therapy: A Case for Early Intervention in High-Risks Pts Assessed By Day 30

Issa F. Khouri, Hyunsoo Hwang, Sattva S. Neelapu, Xuemei Wang, Chitra Hosing, Sairah Ahmed, Partow Kebriaei, May Daher, Amanda L. Olson, Paolo Anderlini, Jin S. Im, Jason Westin, Elizabeth J Shpall, Richard E Champlin, Loretta J. Nastoupil
Journal: Blood
Blood (2022) 140 (Supplement 1): 7502–7503.
https://doi.org/10.1182/blood-2022-166930
Published: 2022
Journal Articles

Cord Derived 8F4CAR-iNKT Cells to Prevent Acute Myeloid Leukemia Relapse and Graft Vs. Host Disease after Allogeneic Stem Cell Transplantation

Maison Grefe, Abel Trujillo-Ocampo, Drew Boagni, Jelita Clinton, Hong He, Karen Clise-Dwyer, Hyunwoo Cho, Elizabeth J Shpall, Jeffrey J. Molldrem, Jin S. Im
Journal: Blood
Blood (2022) 140 (Supplement 1): 4517–4518.
https://doi.org/10.1182/blood-2022-167166
Published: 2022
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Sorafenib in Patients with AML: Results of Phase I Clinical Trial

Uday R. Popat, Roland Bassett, Peter F. Thall, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Naval Daver, Farhad Ravandi, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson, Rohtesh S. Mehta
Journal: Blood
Blood (2021) 138 (Supplement 1): 556.
https://doi.org/10.1182/blood-2021-152450
Published: 2021
Journal Articles

Optimizing Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Regimen: Results of Two Parallel Cohorts in a Phase 2 Prospective Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Katayoun Rezvani, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 1802.
https://doi.org/10.1182/blood-2021-146655
Published: 2021
Journal Articles

Post-Transplant Cyclophosphamide Versus Tacrolimus and Methotrexate to Prevent Graft-Versus-Host Disease in Recipients of Matched Donor Transplantation: Comparison of Sequential Cohorts in a Prospective Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Jitesh D. Kawedia, Issa F. Khouri, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Hagop Kantarjian, Elizabeth J. Shpall, Richard E. Champlin, Borje S. Andersson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2021-146245
Published: 2021
Journal Articles

Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial

Uday R. Popat, Rohtesh S. Mehta, Roland Bassett, Amin M. Alousi, Gheath Alatrash, Qaiser Bashir, Chitra Hosing, Jin S. Im, Partow Kebriaei, Alison Gulbis, David Marin, Yago Nieto, Amanda L. Olson, Betul Oran, Jeremy L. Ramdial, Neeraj Saini, Samer A. Srour, Benigno C. Valdez, Katayoun Rezvani, Muzaffar H. Qazilbash, Tapan M. Kadia, Marina Konopleva, Elizabeth J. Shpall, Borje S. Andersson, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2879.
https://doi.org/10.1182/blood-2021-146253
Published: 2021
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Alison Gulbis, Celina Ledesma, Nitin Jain, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Paolo Anderlini, Qaiser Bashir, MD, May Daher, Partow Kebriaei, MD, David Marin, Rohtesh Mehta, Uday R. Popat, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Jin S. Im, Luis Fayad, Ranjit Nair, MD, Swaminathan P Iyer, MD, Paolo Strati, MD, Felipe Samaniego, MD, Loretta J. Nastoupil, MD, Christopher Flowers, MDMS, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-141985
Published: 2020
Journal Articles

Autologous Vs. Allogeneic Stem Cell Transplantation in Double-Expressor Lymphoma

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Swami P. Iyer, MD, David Marin, Rohtesh Mehta, Amanda L. Olson, Uday R. Popat, MD, Felipe Samaniego, MD, Muzaffar H. Qazilbash, MD, Jin S. Im, Gabriela Rondon, Richard E. Champlin, MD, Alison Gulbis, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138741
Published: 2020
Journal Articles

Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation

Betul Oran, MDMS, Gheath Alatrash, Amin M. Alousi, MD, Rohtesh S. Mehta, MDMPH,MS, Chitra Hosing, MD, Uday R. Popat, MD, Jin S. Im, Jessica M McCarty, RN, Jennifer D Ramos, RN, Harold N. Keer, MDPhD, Peter F Thall, PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29–30.
https://doi.org/10.1182/blood-2020-134272
Published: 2020
Journal Articles

Risk of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem Cell Transplantation (alloSCT) with Venetoclax- Based Therapy

Akash Mukherjee, Denái R. Milton, MS, Elias Jabbour, MD, Naval Daver, MD, Alison Gulbis, Celina Ledesma, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD MSCE, Farhad Ravandi, MBBS, Tapan M. Kadia, MD, Gheath Alatrash, Amin M. Alousi, MD, May Daher, David Marin, Amanda L. Olson, Betul Oran, MDMS, Partow Kebriaei, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Jin S. Im, Rohtesh Mehta, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137097
Published: 2020
Journal Articles

Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft Versus Host Disease

Rohtesh S. Mehta, MDMPH,MS, Rima M. Saliba, PhD, Anna Jan, Terri Lynn Shigle, PharmD, Emily Wang, Gabriela Rondon, Yago Nieto, MD, Stefan Ciurea, MD, Betul Oran, MDMS, Jin S. Im, Amanda L. Olson, David Marin, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Paolo Anderlini, Katayoun Rezvani, MD PhD, Uday R. Popat, MD, Partow Kebriaei, MD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD, Amin M. Alousi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-139283
Published: 2020
Journal Articles

Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma

Issa F. Khouri, MD, Denái R. Milton, MS, Celina Ledesma, Elias Jabbour, MD, Qaiser Bashir, Jin S. Im, Luis Fayad, Hun Ju Lee, MD, Ranjit Nair, Loretta J. Nastoupil, MD, Felipe Samaniego, MD, Swami P. Iyer, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Padmanee Sharma, Alison Gulbis
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–11.
https://doi.org/10.1182/blood-2020-138778
Published: 2020